Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
aHswDwXXHVXhsSMZ